FindTrial
Sign In

A comparative study to evaluate a better pain relief modality for postoperative patients

TRANSVERSUS ABDOMINIS PLANE BLOCK VERSUS QUADRATUS LUMBORUM BLOCK FOR POST OPERATIVE ANALGESIA AFTER LOWER ABDOMINAL SURGERIES USING 0.25% ROPIVACAINE- A COMPARATIVE STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/11/038243
Enrollment
56
Registered
2021-11-25
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G541- Lumbosacral plexus disorders

Interventions

Intervention1: Ropivacaine Quadratus lumborum nerve block: Dose: 20 ml of 0.25% of Ropivacaine. Frequency of administration: Once only Route of administration: Quadratus Lumborum nerve block (Intram

Sponsors

Vydehi Institute of Medical Sciences and Research centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with American Society of Anesthesiologists (ASA) I and II physical status. 2. Patients with age between 18 to 60 years of either sex 3. Elective lower abdominal surgeries. 4. Patients who have given written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with history of allergy to local anaesthetics. 2. Patients with mental illness.

Design outcomes

Primary

MeasureTime frame
â?¢ Time of first rescue analgesic request â?¢ Total analgesic drug requirement Timepoint: 30 minutes, 1 hour, 2 hours, 4 hours, 6 hours, 12 hours, 18 hours, 24 hours—

Secondary

MeasureTime frame
adverse eventsTimepoint: 24 hours—

Countries

India

Contacts

Public ContactDr Salma Naazneen

Vydehi Institute of Medical Sciences and Research Centre

umamahesh024@gmail.com919441249655

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026